 | • レポートコード：QFJ1-4216 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ファーバー病の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術）、用途別市場規模（病院、ホームケア、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ファーバー病の市場動向 ・企業の競争状況、市場シェア ・ファーバー病の種類別市場規模と予測2016-2027（医薬品、手術） ・ファーバー病の用途別市場規模と予測2016-2027（病院、ホームケア、専門クリニック、その他） ・ファーバー病の北米市場規模2016-2027（アメリカ、カナダ） ・ファーバー病の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ファーバー病のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ファーバー病の中南米市場規模2016-2027（メキシコ、ブラジル） ・ファーバー病の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann-La Roche Ltd、Pfizer Inc、GlaxoSmithKline plc、Cardinal Health、Endo Pharmaceuticals Inc、Impax Laboratories、Teva Pharmaceutical Industries Ltd、Mylan N.V、Kowa Pharmaceuticals America、Sun Pharmaceutical Industries Ltd、Glenmark Pharmaceuticals Ltd、WOCKHARDT、Novartis AG、Merck & Co、Takeda Pharmaceutical Company Limited、AstraZeneca、Boehringer Ingelheim International GmbH、Enzyvant） ・結論 |
Farber’s disease is a rare inherited condition involving the breakdown and use of fats in the body. In affected individuals, lipids accumulate abnormally in cells and tissues throughout the body, particularly around the joints. The deficiency of an enzyme is called ceramidase resulting in the harmful accumulation of certain chemicals in the body, which causes damage and inflammation. Three classic signs occur in Farber lipogranulomatosis: a hoarse voice or a weak cry, small lumps of fat under the skin and in other tissues (lipogranulomas), and swollen and painful joints. Affected individuals may also have difficulty breathing, an enlarged liver and spleen (hepatosplenomegaly), and developmental delay.
Market Analysis and Insights: Global Farber’s Disease Market
The global Farber’s Disease market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Farber’s Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Farber’s Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Farber’s Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Farber’s Disease market.
Global Farber’s Disease Scope and Market Size
Farber’s Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Farber’s Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medication
Surgery
Segment by Application
Hospitals
Homecare
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
F. Hoffmann-La Roche Ltd
Pfizer Inc
GlaxoSmithKline plc
Cardinal Health
Endo Pharmaceuticals Inc
Impax Laboratories
Teva Pharmaceutical Industries Ltd
Mylan N.V
Kowa Pharmaceuticals America
Sun Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Ltd
WOCKHARDT
Novartis AG
Merck & Co
Takeda Pharmaceutical Company Limited
AstraZeneca
Boehringer Ingelheim International GmbH
Enzyvant
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Farber’s Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Farber’s Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Farber’s Disease Market Perspective (2016-2027)
2.2 Farber’s Disease Growth Trends by Regions
2.2.1 Farber’s Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Farber’s Disease Historic Market Share by Regions (2016-2021)
2.2.3 Farber’s Disease Forecasted Market Size by Regions (2022-2027)
2.3 Farber’s Disease Industry Dynamic
2.3.1 Farber’s Disease Market Trends
2.3.2 Farber’s Disease Market Drivers
2.3.3 Farber’s Disease Market Challenges
2.3.4 Farber’s Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Farber’s Disease Players by Revenue
3.1.1 Global Top Farber’s Disease Players by Revenue (2016-2021)
3.1.2 Global Farber’s Disease Revenue Market Share by Players (2016-2021)
3.2 Global Farber’s Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Farber’s Disease Revenue
3.4 Global Farber’s Disease Market Concentration Ratio
3.4.1 Global Farber’s Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Farber’s Disease Revenue in 2020
3.5 Farber’s Disease Key Players Head office and Area Served
3.6 Key Players Farber’s Disease Product Solution and Service
3.7 Date of Enter into Farber’s Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Farber’s Disease Breakdown Data by Type
4.1 Global Farber’s Disease Historic Market Size by Type (2016-2021)
4.2 Global Farber’s Disease Forecasted Market Size by Type (2022-2027)
5 Farber’s Disease Breakdown Data by Application
5.1 Global Farber’s Disease Historic Market Size by Application (2016-2021)
5.2 Global Farber’s Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Farber’s Disease Market Size (2016-2027)
6.2 North America Farber’s Disease Market Size by Type
6.2.1 North America Farber’s Disease Market Size by Type (2016-2021)
6.2.2 North America Farber’s Disease Market Size by Type (2022-2027)
6.2.3 North America Farber’s Disease Market Size by Type (2016-2027)
6.3 North America Farber’s Disease Market Size by Application
6.3.1 North America Farber’s Disease Market Size by Application (2016-2021)
6.3.2 North America Farber’s Disease Market Size by Application (2022-2027)
6.3.3 North America Farber’s Disease Market Size by Application (2016-2027)
6.4 North America Farber’s Disease Market Size by Country
6.4.1 North America Farber’s Disease Market Size by Country (2016-2021)
6.4.2 North America Farber’s Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Farber’s Disease Market Size (2016-2027)
7.2 Europe Farber’s Disease Market Size by Type
7.2.1 Europe Farber’s Disease Market Size by Type (2016-2021)
7.2.2 Europe Farber’s Disease Market Size by Type (2022-2027)
7.2.3 Europe Farber’s Disease Market Size by Type (2016-2027)
7.3 Europe Farber’s Disease Market Size by Application
7.3.1 Europe Farber’s Disease Market Size by Application (2016-2021)
7.3.2 Europe Farber’s Disease Market Size by Application (2022-2027)
7.3.3 Europe Farber’s Disease Market Size by Application (2016-2027)
7.4 Europe Farber’s Disease Market Size by Country
7.4.1 Europe Farber’s Disease Market Size by Country (2016-2021)
7.4.2 Europe Farber’s Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Farber’s Disease Market Size (2016-2027)
8.2 Asia-Pacific Farber’s Disease Market Size by Type
8.2.1 Asia-Pacific Farber’s Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Farber’s Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Farber’s Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Farber’s Disease Market Size by Application
8.3.1 Asia-Pacific Farber’s Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Farber’s Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Farber’s Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Farber’s Disease Market Size by Region
8.4.1 Asia-Pacific Farber’s Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Farber’s Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Farber’s Disease Market Size (2016-2027)
9.2 Latin America Farber’s Disease Market Size by Type
9.2.1 Latin America Farber’s Disease Market Size by Type (2016-2021)
9.2.2 Latin America Farber’s Disease Market Size by Type (2022-2027)
9.2.3 Latin America Farber’s Disease Market Size by Type (2016-2027)
9.3 Latin America Farber’s Disease Market Size by Application
9.3.1 Latin America Farber’s Disease Market Size by Application (2016-2021)
9.3.2 Latin America Farber’s Disease Market Size by Application (2022-2027)
9.3.3 Latin America Farber’s Disease Market Size by Application (2016-2027)
9.4 Latin America Farber’s Disease Market Size by Country
9.4.1 Latin America Farber’s Disease Market Size by Country (2016-2021)
9.4.2 Latin America Farber’s Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Farber’s Disease Market Size (2016-2027)
10.2 Middle East & Africa Farber’s Disease Market Size by Type
10.2.1 Middle East & Africa Farber’s Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Farber’s Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Farber’s Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Farber’s Disease Market Size by Application
10.3.1 Middle East & Africa Farber’s Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Farber’s Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Farber’s Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Farber’s Disease Market Size by Country
10.4.1 Middle East & Africa Farber’s Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Farber’s Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd Farber’s Disease Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in Farber’s Disease Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Ltd Recent Development
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Details
11.2.2 Pfizer Inc Business Overview
11.2.3 Pfizer Inc Farber’s Disease Introduction
11.2.4 Pfizer Inc Revenue in Farber’s Disease Business (2016-2021)
11.2.5 Pfizer Inc Recent Development
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Details
11.3.2 GlaxoSmithKline plc Business Overview
11.3.3 GlaxoSmithKline plc Farber’s Disease Introduction
11.3.4 GlaxoSmithKline plc Revenue in Farber’s Disease Business (2016-2021)
11.3.5 GlaxoSmithKline plc Recent Development
11.4 Cardinal Health
11.4.1 Cardinal Health Company Details
11.4.2 Cardinal Health Business Overview
11.4.3 Cardinal Health Farber’s Disease Introduction
11.4.4 Cardinal Health Revenue in Farber’s Disease Business (2016-2021)
11.4.5 Cardinal Health Recent Development
11.5 Endo Pharmaceuticals Inc
11.5.1 Endo Pharmaceuticals Inc Company Details
11.5.2 Endo Pharmaceuticals Inc Business Overview
11.5.3 Endo Pharmaceuticals Inc Farber’s Disease Introduction
11.5.4 Endo Pharmaceuticals Inc Revenue in Farber’s Disease Business (2016-2021)
11.5.5 Endo Pharmaceuticals Inc Recent Development
11.6 Impax Laboratories
11.6.1 Impax Laboratories Company Details
11.6.2 Impax Laboratories Business Overview
11.6.3 Impax Laboratories Farber’s Disease Introduction
11.6.4 Impax Laboratories Revenue in Farber’s Disease Business (2016-2021)
11.6.5 Impax Laboratories Recent Development
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Company Details
11.7.2 Teva Pharmaceutical Industries Ltd Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd Farber’s Disease Introduction
11.7.4 Teva Pharmaceutical Industries Ltd Revenue in Farber’s Disease Business (2016-2021)
11.7.5 Teva Pharmaceutical Industries Ltd Recent Development
11.8 Mylan N.V
11.8.1 Mylan N.V Company Details
11.8.2 Mylan N.V Business Overview
11.8.3 Mylan N.V Farber’s Disease Introduction
11.8.4 Mylan N.V Revenue in Farber’s Disease Business (2016-2021)
11.8.5 Mylan N.V Recent Development
11.9 Kowa Pharmaceuticals America
11.9.1 Kowa Pharmaceuticals America Company Details
11.9.2 Kowa Pharmaceuticals America Business Overview
11.9.3 Kowa Pharmaceuticals America Farber’s Disease Introduction
11.9.4 Kowa Pharmaceuticals America Revenue in Farber’s Disease Business (2016-2021)
11.9.5 Kowa Pharmaceuticals America Recent Development
11.10 Sun Pharmaceutical Industries Ltd
11.10.1 Sun Pharmaceutical Industries Ltd Company Details
11.10.2 Sun Pharmaceutical Industries Ltd Business Overview
11.10.3 Sun Pharmaceutical Industries Ltd Farber’s Disease Introduction
11.10.4 Sun Pharmaceutical Industries Ltd Revenue in Farber’s Disease Business (2016-2021)
11.10.5 Sun Pharmaceutical Industries Ltd Recent Development
11.11 Glenmark Pharmaceuticals Ltd
11.11.1 Glenmark Pharmaceuticals Ltd Company Details
11.11.2 Glenmark Pharmaceuticals Ltd Business Overview
11.11.3 Glenmark Pharmaceuticals Ltd Farber’s Disease Introduction
11.11.4 Glenmark Pharmaceuticals Ltd Revenue in Farber’s Disease Business (2016-2021)
11.11.5 Glenmark Pharmaceuticals Ltd Recent Development
11.12 WOCKHARDT
11.12.1 WOCKHARDT Company Details
11.12.2 WOCKHARDT Business Overview
11.12.3 WOCKHARDT Farber’s Disease Introduction
11.12.4 WOCKHARDT Revenue in Farber’s Disease Business (2016-2021)
11.12.5 WOCKHARDT Recent Development
11.13 Novartis AG
11.13.1 Novartis AG Company Details
11.13.2 Novartis AG Business Overview
11.13.3 Novartis AG Farber’s Disease Introduction
11.13.4 Novartis AG Revenue in Farber’s Disease Business (2016-2021)
11.13.5 Novartis AG Recent Development
11.14 Merck & Co
11.14.1 Merck & Co Company Details
11.14.2 Merck & Co Business Overview
11.14.3 Merck & Co Farber’s Disease Introduction
11.14.4 Merck & Co Revenue in Farber’s Disease Business (2016-2021)
11.14.5 Merck & Co Recent Development
11.15 Takeda Pharmaceutical Company Limited
11.15.1 Takeda Pharmaceutical Company Limited Company Details
11.15.2 Takeda Pharmaceutical Company Limited Business Overview
11.15.3 Takeda Pharmaceutical Company Limited Farber’s Disease Introduction
11.15.4 Takeda Pharmaceutical Company Limited Revenue in Farber’s Disease Business (2016-2021)
11.15.5 Takeda Pharmaceutical Company Limited Recent Development
11.16 AstraZeneca
11.16.1 AstraZeneca Company Details
11.16.2 AstraZeneca Business Overview
11.16.3 AstraZeneca Farber’s Disease Introduction
11.16.4 AstraZeneca Revenue in Farber’s Disease Business (2016-2021)
11.16.5 AstraZeneca Recent Development
11.17 Boehringer Ingelheim International GmbH
11.17.1 Boehringer Ingelheim International GmbH Company Details
11.17.2 Boehringer Ingelheim International GmbH Business Overview
11.17.3 Boehringer Ingelheim International GmbH Farber’s Disease Introduction
11.17.4 Boehringer Ingelheim International GmbH Revenue in Farber’s Disease Business (2016-2021)
11.17.5 Boehringer Ingelheim International GmbH Recent Development
11.18 Enzyvant
11.18.1 Enzyvant Company Details
11.18.2 Enzyvant Business Overview
11.18.3 Enzyvant Farber’s Disease Introduction
11.18.4 Enzyvant Revenue in Farber’s Disease Business (2016-2021)
11.18.5 Enzyvant Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Farber's Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication
Table 3. Key Players of Surgery
Table 4. Global Farber's Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Farber's Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Farber's Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Farber's Disease Market Share by Regions (2016-2021)
Table 8. Global Farber's Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Farber's Disease Market Share by Regions (2022-2027)
Table 10. Farber's Disease Market Trends
Table 11. Farber's Disease Market Drivers
Table 12. Farber's Disease Market Challenges
Table 13. Farber's Disease Market Restraints
Table 14. Global Farber's Disease Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Farber's Disease Market Share by Players (2016-2021)
Table 16. Global Top Farber's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Farber's Disease as of 2020)
Table 17. Ranking of Global Top Farber's Disease Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Farber's Disease Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Farber's Disease Product Solution and Service
Table 21. Date of Enter into Farber's Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Farber's Disease Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Farber's Disease Revenue Market Share by Type (2016-2021)
Table 25. Global Farber's Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Farber's Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Farber's Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Farber's Disease Revenue Market Share by Application (2016-2021)
Table 29. Global Farber's Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Farber's Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Farber's Disease Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Farber's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Farber's Disease Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Farber's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Farber's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Farber's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Farber's Disease Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Farber's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Farber's Disease Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Farber's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Farber's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Farber's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Farber's Disease Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Farber's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Farber's Disease Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Farber's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Farber's Disease Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Farber's Disease Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Farber's Disease Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Farber's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Farber's Disease Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Farber's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Farber's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Farber's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Farber's Disease Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Farber's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Farber's Disease Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Farber's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Farber's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Farber's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 61. F. Hoffmann-La Roche Ltd Company Details
Table 62. F. Hoffmann-La Roche Ltd Business Overview
Table 63. F. Hoffmann-La Roche Ltd Farber's Disease Product
Table 64. F. Hoffmann-La Roche Ltd Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 65. F. Hoffmann-La Roche Ltd Recent Development
Table 66. Pfizer Inc Company Details
Table 67. Pfizer Inc Business Overview
Table 68. Pfizer Inc Farber's Disease Product
Table 69. Pfizer Inc Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 70. Pfizer Inc Recent Development
Table 71. GlaxoSmithKline plc Company Details
Table 72. GlaxoSmithKline plc Business Overview
Table 73. GlaxoSmithKline plc Farber's Disease Product
Table 74. GlaxoSmithKline plc Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 75. GlaxoSmithKline plc Recent Development
Table 76. Cardinal Health Company Details
Table 77. Cardinal Health Business Overview
Table 78. Cardinal Health Farber's Disease Product
Table 79. Cardinal Health Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 80. Cardinal Health Recent Development
Table 81. Endo Pharmaceuticals Inc Company Details
Table 82. Endo Pharmaceuticals Inc Business Overview
Table 83. Endo Pharmaceuticals Inc Farber's Disease Product
Table 84. Endo Pharmaceuticals Inc Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 85. Endo Pharmaceuticals Inc Recent Development
Table 86. Impax Laboratories Company Details
Table 87. Impax Laboratories Business Overview
Table 88. Impax Laboratories Farber's Disease Product
Table 89. Impax Laboratories Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 90. Impax Laboratories Recent Development
Table 91. Teva Pharmaceutical Industries Ltd Company Details
Table 92. Teva Pharmaceutical Industries Ltd Business Overview
Table 93. Teva Pharmaceutical Industries Ltd Farber's Disease Product
Table 94. Teva Pharmaceutical Industries Ltd Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 95. Teva Pharmaceutical Industries Ltd Recent Development
Table 96. Mylan N.V Company Details
Table 97. Mylan N.V Business Overview
Table 98. Mylan N.V Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 99. Mylan N.V Recent Development
Table 100. Kowa Pharmaceuticals America Company Details
Table 101. Kowa Pharmaceuticals America Business Overview
Table 102. Kowa Pharmaceuticals America Farber's Disease Product
Table 103. Kowa Pharmaceuticals America Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 104. Kowa Pharmaceuticals America Recent Development
Table 105. Sun Pharmaceutical Industries Ltd Company Details
Table 106. Sun Pharmaceutical Industries Ltd Business Overview
Table 107. Sun Pharmaceutical Industries Ltd Farber's Disease Product
Table 108. Sun Pharmaceutical Industries Ltd Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 109. Sun Pharmaceutical Industries Ltd Recent Development
Table 110. Glenmark Pharmaceuticals Ltd Company Details
Table 111. Glenmark Pharmaceuticals Ltd Business Overview
Table 112. Glenmark Pharmaceuticals Ltd Farber's Disease Product
Table 113. Glenmark Pharmaceuticals Ltd Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 114. Glenmark Pharmaceuticals Ltd Recent Development
Table 115. WOCKHARDT Company Details
Table 116. WOCKHARDT Business Overview
Table 117. WOCKHARDT Farber's Disease Product
Table 118. WOCKHARDT Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 119. WOCKHARDT Recent Development
Table 120. Novartis AG Company Details
Table 121. Novartis AG Business Overview
Table 122. Novartis AG Farber's Disease Product
Table 123. Novartis AG Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 124. Novartis AG Recent Development
Table 125. Merck & Co Company Details
Table 126. Merck & Co Business Overview
Table 127. Merck & Co Farber's Disease Product
Table 128. Merck & Co Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 129. Merck & Co Recent Development
Table 130. Takeda Pharmaceutical Company Limited Company Details
Table 131. Takeda Pharmaceutical Company Limited Business Overview
Table 132. Takeda Pharmaceutical Company Limited Farber's Disease Product
Table 133. Takeda Pharmaceutical Company Limited Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 134. Takeda Pharmaceutical Company Limited Recent Development
Table 135. AstraZeneca Company Details
Table 136. AstraZeneca Business Overview
Table 137. AstraZeneca Farber's Disease Product
Table 138. AstraZeneca Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 139. AstraZeneca Recent Development
Table 140. Boehringer Ingelheim International GmbH Company Details
Table 141. Boehringer Ingelheim International GmbH Business Overview
Table 142. Boehringer Ingelheim International GmbH Farber's Disease Product
Table 143. Boehringer Ingelheim International GmbH Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 144. Boehringer Ingelheim International GmbH Recent Development
Table 145. Enzyvant Company Details
Table 146. Enzyvant Business Overview
Table 147. Enzyvant Farber's Disease Product
Table 148. Enzyvant Revenue in Farber's Disease Business (2016-2021) & (US$ Million)
Table 149. Enzyvant Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Farber's Disease Market Share by Type: 2020 VS 2027
Figure 2. Medication Features
Figure 3. Surgery Features
Figure 4. Global Farber's Disease Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Homecare Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Farber's Disease Report Years Considered
Figure 10. Global Farber's Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Farber's Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Farber's Disease Market Share by Regions: 2020 VS 2027
Figure 13. Global Farber's Disease Market Share by Regions (2022-2027)
Figure 14. Global Farber's Disease Market Share by Players in 2020
Figure 15. Global Top Farber's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Farber's Disease as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Farber's Disease Revenue in 2020
Figure 17. Global Farber's Disease Revenue Market Share by Type (2016-2021)
Figure 18. Global Farber's Disease Revenue Market Share by Type (2022-2027)
Figure 19. North America Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Farber's Disease Market Share by Type (2016-2027)
Figure 21. North America Farber's Disease Market Share by Application (2016-2027)
Figure 22. North America Farber's Disease Market Share by Country (2016-2027)
Figure 23. United States Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Farber's Disease Market Share by Type (2016-2027)
Figure 27. Europe Farber's Disease Market Share by Application (2016-2027)
Figure 28. Europe Farber's Disease Market Share by Country (2016-2027)
Figure 29. Germany Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Farber's Disease Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Farber's Disease Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Farber's Disease Market Share by Region (2016-2027)
Figure 39. China Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Farber's Disease Market Share by Type (2016-2027)
Figure 47. Latin America Farber's Disease Market Share by Application (2016-2027)
Figure 48. Latin America Farber's Disease Market Share by Country (2016-2027)
Figure 49. Mexico Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Farber's Disease Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Farber's Disease Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Farber's Disease Market Share by Country (2016-2027)
Figure 55. Turkey Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Farber's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 59. Pfizer Inc Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 60. GlaxoSmithKline plc Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 61. Cardinal Health Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 62. Endo Pharmaceuticals Inc Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 63. Impax Laboratories Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 64. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 65. Mylan N.V Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 66. Kowa Pharmaceuticals America Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 67. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 68. Glenmark Pharmaceuticals Ltd Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 69. WOCKHARDT Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 70. Novartis AG Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 71. Merck & Co Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 72. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 73. AstraZeneca Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 74. Boehringer Ingelheim International GmbH Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 75. Enzyvant Revenue Growth Rate in Farber's Disease Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の転移性骨疾患薬物治療市場規模・現状・予測（2021年-2027年） Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. Market Analysis and Insights: Global Medication Treatment …- 世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界のメニエール病治療薬パイプライン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Meniere Disease Drug Pipeline Market The global Meniere Disease Drug Pipeline market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
- 世界のバッテン病治療市場規模・現状・予測（2021年-2027年） Batten disease is inherited disorder of the nervous system which begins in childhood.It is also called as neuronal ceroid lipofuscinoses (or NCLs). Batten Disease Treatment is the treatment of this type of disease. Market Analysis and Insights: Global Batten Disease Treatment Market The global Batte…
- 世界の甲状腺眼症治療市場規模・現状・予測（2021年-2027年） Thyroid eye disease is the inflammation of the eye muscles, eyelids, tear glands and fatty tissues behind the eye. The inflammation leads to swelling of the eye, eyes and eyelids become red and eye ca be pushed forward. The movement of the eye also affects, as both eyes do not move in sync which may…